Diltiazem in Non-Q-Wave Myocardial Infarction

Richard A. Reeves, Lawrence J. Jacobs, Jeffery L. Curtis, Robert Roberts, Robert G. Gibson, Kenneth Schechtman

Research output: Contribution to journalLetterpeer-review

1 Scopus citations


To the Editor: The Diltiazem Reinfarction Study Group has conducted a well-designed prospective clinical trial comparing diltiazem with placebo in non-Q-wave myocardial infarction (Aug. 14 issue).1 Although the data were interpreted to indicate a beneficial effect of diltiazem, the analysis employed may not be appropriate to the question asked. The primary end point chosen was the occurrence of reinfarction during a 14-day period. The type of hypothesis examined (no difference between drug groups) can be tested by a chi-square test. Instead, the authors employed life-table analysis, a technique appropriate when both the presence or absence of an end point and…

Original languageEnglish
Pages (from-to)220-221
Number of pages2
JournalNew England Journal of Medicine
Issue number4
StatePublished - Jan 22 1987


Dive into the research topics of 'Diltiazem in Non-Q-Wave Myocardial Infarction'. Together they form a unique fingerprint.

Cite this